Targeting ISR-GDF15-mediated mitochondrial retrograde signaling might be a possible treatment modality against cancer progression.Recently, ghost mitochondria in cancer were proposed to address the controversy of mitochondrial reprogramming as a tumor driver [25]. The gene discussed is GDF15; the disease is cancer.